Investigation Overview
January 3, 2017 (Shareholders Foundation) - An investigation on behalf of investors of Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) shares over potential securities laws violations by Amphastar Pharmaceuticals and certain of its directors and officers in connection certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purch...
You must register (for free) or login to view the entire investigation.